Table: Chordia Therapeutics -2023/24 parent results

Chordia Therapeutics

11/10/2024 01:00

Oct 11 (Reuters)- 
          Chordia Therapeutics Inc. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended        Year to        NEXT   
              Aug 31, 2024    Aug 31, 2023    Aug 31, 2025      YEAR     
                 LATEST         YEAR-AGO         COMPANY       COMPANY   
                 RESULTS         RESULTS        FORECAST     H1 FORECAST 
  Sales                           2.50                                   
  Operating     loss 1.80        212 mln        loss 2.43                
  Recurring     loss 1.82        225 mln        loss 2.38                
  Net           loss 1.83        223 mln        loss 2.38                
  EPS        loss 31.11 yen     3.96 yen     loss 35.17 yen              
  Ann Div          NIL             NIL             NIL                   
  -Q2 Div          NIL             NIL             NIL                   
  -Q4 Div          NIL             NIL             NIL                   
  
  NOTE - Chordia Therapeutics Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=190A.T